Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Demarest

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Virology|April 23, 2010
HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cellsJennifer M Pfaff, Craig B Wilen, Jessamina E Harrison, et al.
Immunological Reviews|August 1, 1994
Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infectionG Pantaleo, C Graziosi, J F Demarest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2025
The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic PreparednessRuxandra Draghia-Akli, Nina M Hill, Bruce Altevogt, et al.
Science (New York, N.Y.)|July 8, 1994
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individualsC Graziosi, G Pantaleo, K R Gantt, et al.
Viruses|January 22, 2022
Activity of Galidesivir in a Hamster Model of SARS-CoV-2Ray Taylor, Richard Bowen, James F Demarest, et al.
Nature|March 25, 1993
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of diseaseG Pantaleo, C Graziosi, J F Demarest, et al.
The New England Journal of Medicine|January 26, 1995
Studies in subjects with long-term nonprogressive human immunodeficiency virus infectionG Pantaleo, S Menzo, M Vaccarezza, et al.
Journal of Clinical Pharmacology|August 5, 2008
In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of AplavirocJames F Demarest, Sara S Sparks, Kathleen Schell, et al.
Blood|February 26, 2000
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonalityH Soudeyns, G Campi, G P Rizzardi, et al.
Nature Medicine|April 1, 1995
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progressionS Koenig, A J Conley, Y A Brewah, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Virology|April 23, 2010
HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cellsJennifer M Pfaff, Craig B Wilen, Jessamina E Harrison, et al.
Immunological Reviews|August 1, 1994
Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infectionG Pantaleo, C Graziosi, J F Demarest, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 2, 2025
The Indispensable Value of Small-Molecule Antivirals in Epidemic and Pandemic PreparednessRuxandra Draghia-Akli, Nina M Hill, Bruce Altevogt, et al.
Science (New York, N.Y.)|July 8, 1994
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individualsC Graziosi, G Pantaleo, K R Gantt, et al.
Viruses|January 22, 2022
Activity of Galidesivir in a Hamster Model of SARS-CoV-2Ray Taylor, Richard Bowen, James F Demarest, et al.
Nature|March 25, 1993
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of diseaseG Pantaleo, C Graziosi, J F Demarest, et al.
The New England Journal of Medicine|January 26, 1995
Studies in subjects with long-term nonprogressive human immunodeficiency virus infectionG Pantaleo, S Menzo, M Vaccarezza, et al.
Journal of Clinical Pharmacology|August 5, 2008
In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of AplavirocJames F Demarest, Sara S Sparks, Kathleen Schell, et al.
Blood|February 26, 2000
Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonalityH Soudeyns, G Campi, G P Rizzardi, et al.
Nature Medicine|April 1, 1995
Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progressionS Koenig, A J Conley, Y A Brewah, et al.
Pageof 4